000 00949 a2200265 4500
005 20250513184159.0
264 0 _c19990623
008 199906s 0 0 eng d
022 _a0007-0912
024 7 _a10.1093/bja/82.2.299-a
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWoolf, R L
245 0 0 _aEarly clinical experience with a newly formulated hydroxyethyl starch--Hextend.
_h[electronic resource]
260 _bBritish journal of anaesthesia
_cFeb 1999
300 _a299-300 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aHemodilution
_xmethods
650 0 4 _aHumans
650 0 4 _aHydroxyethyl Starch Derivatives
_xtherapeutic use
650 0 4 _aPlasma Substitutes
_xtherapeutic use
700 1 _aChapman, M V
700 1 _aMythen, M G
773 0 _tBritish journal of anaesthesia
_gvol. 82
_gno. 2
_gp. 299-300
856 4 0 _uhttps://doi.org/10.1093/bja/82.2.299-a
_zAvailable from publisher's website
999 _c10323558
_d10323558